VeriMomdisodium c12-14 sec-pareth-7 sulfosuccinate hamilelikte güvenli mi?
No harmonised CLP reproductive classifications found (ECHA Annex VI). No CIR or SCCS safety assessment flagging reproductive toxicity, and PubMed contains no credible reproductive/toxicology studies indicating teratogenicity or reproductive hazards for this specific sulfosuccinate; ECHA/PubChem entries list typical surfactant toxicology (irritation at high concentrations) but not reproductive endpoints. Topical cosmetic use would give low but measurable dermal exposure (surfactants have limited systemic absorption). Sources: ECHA Annex VI (no harmonised repro classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- disodium c12-14 sec-pareth-7 sulfosuccinate hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications found (ECHA Annex VI). No CIR or SCCS safety assessment flagging reproductive toxicity, and PubMed contains no credible reproductive/toxicology studies indicating teratogenicity or reproductive hazards for this specific sulfosuccinate; ECHA/PubChem entries list typical surfactant toxicology (irritation at high concentrations) but not reproductive endpoints. Topical cosmetic use would give low but measurable dermal exposure (surfactants have limited systemic absorption). Sources: ECHA Annex VI (no harmonised repro classification), PubChem, CosIng, PubMed (no reproductive studies found).
- disodium c12-14 sec-pareth-7 sulfosuccinate emzirirken güvenli mi?
- No data indicating reproductive or lactation toxicity or transfer into milk in ECHA/CIR/SCCS/PubMed sources. Mechanistic data for placental/milk transfer are absent. Dermal exposure in lactating persons is expected to be low but measurable; no evidence of systemic accumulation or endocrine activity that would raise concern. Sources: ECHA (registration/Cosing entries), PubChem, PubMed (no lactation studies).
- disodium c12-14 sec-pareth-7 sulfosuccinate bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data were identified. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight ratio, exposure score is increased by +1 versus adults (adult e=1 → infant e=2). No evidence found for specific mechanisms (endocrine activity) or harmonised reproductive hazards. Sources: CosIng, ECHA registrations, PubChem, PubMed (no infant dermal absorption/reprotox studies).
- VeriMom disodium c12-14 sec-pareth-7 sulfosuccinate nasıl puanlıyor?
- VeriMom disodium c12-14 sec-pareth-7 sulfosuccinate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte disodium c12-14 sec-pareth-7 sulfosuccinate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.